Show notes
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Steve Levine, MD, Chief Patient Officer at Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health.
One of the areas that Compass Pathways is working in is the development of psilocybin-based treatments for treatment-resistant depression (TRD).
Dr. Levine is a board-certified psychiatrist who has spent his career working across multiple facets of the healthcare system to improve people’s…
Website: xtalkslifescience.podbean.com

